{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:21:59Z","timestamp":1787862119640,"version":"build-2784847793"},"reference-count":65,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014786","name":"Northern Border University","doi-asserted-by":"publisher","award":["NBU-FFR-2026-3770-12"],"award-info":[{"award-number":["NBU-FFR-2026-3770-12"]}],"id":[{"id":"10.13039\/501100014786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jiph.2026.103312","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:27:39Z","timestamp":1784647659000},"page":"103312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Occult hepatitis B infection in Saudi Arabia: Molecular mechanisms, diagnostic challenges, and implications for HBV elimination"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5765-4580","authenticated-orcid":false,"given":"Shuaibu Abdullahi","family":"Hudu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad A.","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghusun M.","family":"Alhazimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-9100","authenticated-orcid":false,"given":"Abdulgafar Olayiwola","family":"Jimoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2026.103312_bib1","series-title":"Global hepatitis report 2024: Action for access in low-and middle-income countries. Global hepatitis report 2024: Action for access in low-and middle-income countries","author":"WHO","year":"2024"},{"issue":"6","key":"10.1016\/j.jiph.2026.103312_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2468-1253(25)00375-9","article-title":"The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report","volume":"11","author":"Cui","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103312_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jiph.2026.103312_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251387447","article-title":"Occult hepatitis B virus infection and its demographic and clinical determinants among blood donors in Saudi Arabia: a retrospective cross-sectional study","volume":"53","author":"Alrezaihi","year":"2025","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/j.jiph.2026.103312_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-4453(99)90245-1","article-title":"Seroepidemiology of Hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme","volume":"38","author":"Ai-Faleh","year":"1999","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jiph.2026.103312_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5144\/0256-4947.2013.591","article-title":"Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia","volume":"33","author":"Hudu","year":"2013","journal-title":"Ann Saudi Med"},{"issue":"6","key":"10.1016\/j.jiph.2026.103312_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00705-026-06639-9","article-title":"Molecular insights into the mechanisms of occult hepatitis B virus infection","volume":"171","author":"Mahdavi","year":"2026","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103312_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17474124.2025.2611857","article-title":"Occult hepatitis B infection \u2013 unveiling clinical burden and new diagnostic strategies","volume":"20","author":"Soriano","year":"2026","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"23","key":"10.1016\/j.jiph.2026.103312_bib9","article-title":"Prevalence and implications of occult hepatitis B virus infection among blood donors in Saudi Arabia: a systematic review and meta-analysis","volume":"15","author":"Tounsi","year":"2025","journal-title":"Diagn (Basel)"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-024-02366-2","article-title":"Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients","volume":"21","author":"Liu","year":"2024","journal-title":"Virol J"},{"key":"10.1016\/j.jiph.2026.103312_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.104051","article-title":"Molecular epidemiology, phylogenetic analysis and genotype distribution of hepatitis B virus in Saudi Arabia: predominance of genotype D1","volume":"77","author":"Al-Qahtani","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103312_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/vox.13592","article-title":"International review of blood donation nucleic acid amplification testing","volume":"119","author":"Faddy","year":"2024","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.jiph.2026.103312_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jvh.13660","article-title":"Global prevalence of occult hepatitis B: a systematic review and meta-analysis","volume":"29","author":"Ji","year":"2022","journal-title":"J Viral Hepat"},{"issue":"12","key":"10.1016\/j.jiph.2026.103312_bib14","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jiph.2022.11.008","article-title":"Epidemiology of occult hepatitis B and C in Africa: a systematic review and meta-analysis","volume":"15","author":"Ondigui","year":"2022","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s44313-024-00014-w","article-title":"Transfusion-transmitted infections","volume":"59","author":"Kim","year":"2024","journal-title":"Blood Res"},{"issue":"12","key":"10.1016\/j.jiph.2026.103312_bib16","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.15537\/smj.2022.43.12.20220634","article-title":"Prevalence of transfusion-transmitted infections in Saudi Arabia blood donors: a nationwide, cross-sectional study","volume":"43","author":"Alsughayyir","year":"2022","journal-title":"Saudi Med J"},{"issue":"3","key":"10.1016\/j.jiph.2026.103312_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4314\/ahs.v16i3.6","article-title":"Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia","volume":"16","author":"Hudu","year":"2016","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.jiph.2026.103312_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2024.100176","article-title":"Immune response to occult hepatitis B virus infection among hemodialysis patients: a review","volume":"5","author":"Mussa","year":"2024","journal-title":"Microbe"},{"issue":"7","key":"10.1016\/j.jiph.2026.103312_bib19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jiph.2023.05.003","article-title":"Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: implications and perspective","volume":"16","author":"Athalye","year":"2023","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.jiph.2026.103312_bib20","doi-asserted-by":"crossref","DOI":"10.4103\/sccj.sccj_3_18","article-title":"Serological Characterization of Occult Hepatitis B Virus Infection in Riyadh Regional Laboratory","volume":"1","author":"Al-Hababi","year":"2017","journal-title":"Saudi Crit Care J"},{"issue":"4","key":"10.1016\/j.jiph.2026.103312_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.36233\/0507-4088-291","article-title":"Occult hepatitis B: prevalence and clinical significance. Role in liver pathology and in viral coinfections","volume":"70","author":"Kushch","year":"2025","journal-title":"Probl Virol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103312_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4254\/wjh.v5.i2.64","article-title":"Occult hepatitis B virus infection among Egyptian blood donors","volume":"5","author":"Said","year":"2013","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s42506-023-00138-4","article-title":"Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis","volume":"98","author":"Azzam","year":"2023","journal-title":"J Egypt Public Health Assoc"},{"issue":"8","key":"10.1016\/j.jiph.2026.103312_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1466","article-title":"Occult hepatitis B in Iranian blood donors, an overview of the challenges: a narrative review","volume":"6","author":"Ahmadi","year":"2023","journal-title":"Health Sci Rep"},{"issue":"0","key":"10.1016\/j.jiph.2026.103312_bib25","article-title":"Voluntary and non-remunerated blood donation by 2025? A comparative study of blood donor eligibility in 19 healthcare institutions in Lebanon","volume":"0","author":"Chatila","year":"2026","journal-title":"J Health Psychol"},{"issue":"7","key":"10.1016\/j.jiph.2026.103312_bib26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10096-015-2358-1","article-title":"Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees","volume":"34","author":"Hudu","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1186\/s12879-025-11798-2","article-title":"Comprehensive evaluation of NAT+\/HBsAg-blood donors: confirmation strategies, serial testing outcomes, and S gene mutations associated with occult HBV infection","volume":"25","author":"Du","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/ajts.AJTS_157_18","article-title":"Reappraisal of screening strategy in hepatitis B surface antigen-negative blood donors: correlation with hepatitis B virus-DNA quantification","volume":"16","author":"Alam","year":"2022","journal-title":"Asian J Transfus Sci"},{"issue":"11","key":"10.1016\/j.jiph.2026.103312_bib29","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/trf.18018","article-title":"International review of blood donation screening for anti-HBc and occult hepatitis B virus infection","volume":"64","author":"Fu","year":"2024","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib30","article-title":"Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA","volume":"12","author":"Ren","year":"2025","journal-title":"Genes & Dis"},{"issue":"10","key":"10.1016\/j.jiph.2026.103312_bib31","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s11010-023-04660-z","article-title":"The role of HBV cccDNA in occult hepatitis B virus infection","volume":"478","author":"He","year":"2023","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"10.1016\/j.jiph.2026.103312_bib32","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3748\/wjg.v30.i10.1295","article-title":"Overview of the immunological mechanisms in hepatitis B virus reactivation: implications for disease progression and management strategies","volume":"30","author":"Ma","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"14","key":"10.1016\/j.jiph.2026.103312_bib33","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1128\/JVI.00710-13","article-title":"Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection","volume":"87","author":"Biswas","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jiph.2026.103312_bib34","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fcimb.2024.1368473","article-title":"Frequency of HBsAg variants in occult hepatitis B virus infected patients and detection by ARCHITECT HBsAg quantitative","volume":"14","author":"He","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/biom15010062","article-title":"HBV cccDNA: the molecular reservoir of hepatitis B persistence and challenges to achieve viral eradication","volume":"15","author":"Boonstra","year":"2025","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.jiph.2026.103312_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00658-23","article-title":"Virus hijacking of host epigenetic machinery to impair immune response","volume":"97","author":"Locatelli","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.jiph.2026.103312_bib37","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fmicb.2020.616023","article-title":"Comprehensive analysis of clinically significant hepatitis B virus mutations in relation to genotype, subgenotype and geographic region","volume":"11","author":"Araujo","year":"2020","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.jiph.2026.103312_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.115844","article-title":"Cholesterol metabolism dysregulated by key HBV mutations revealed through multi-omics profiling","volume":"29","author":"Chen","year":"2026","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.00018-11","article-title":"Molecular mechanisms underlying occult hepatitis B virus infection","volume":"25","author":"Samal","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.jiph.2026.103312_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome","volume":"81","author":"Zoulim","year":"2024","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jiph.2026.103312_bib41","doi-asserted-by":"crossref","first-page":"e01105","DOI":"10.1128\/jvi.01105-23","article-title":"DAA-mediated HCV cure reduces HIV DNA levels in HCV\/HIV coinfected people","volume":"97","author":"Gobran","year":"2023","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.jiph.2026.103312_bib42","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.jiph.2026.103312_bib43","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2011-301281","article-title":"Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence","volume":"61","author":"Candotti","year":"2012","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.jiph.2026.103312_bib44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3748\/wjg.v17.i12.1553","article-title":"Diagnostic strategy for occult hepatitis B virus infection","volume":"17","author":"Ocana","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jiph.2026.103312_bib45","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3390\/v14102263","article-title":"Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection Risk","volume":"14","author":"Lelie","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2026.103312_bib46","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2025.1663306","article-title":"Transfusion-transmitted occult hepatitis B virus infection: current understanding, challenges, and its implication in blood safety","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jiph.2026.103312_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25805","article-title":"Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low resource setting","volume":"10","author":"Athalye","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12879-024-09786-z","article-title":"Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China","volume":"24","author":"Ye","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"17","key":"10.1016\/j.jiph.2026.103312_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37097","article-title":"An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination","volume":"10","author":"Delghandi","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/pathogens13010046","article-title":"Hepatitis B surface antigen isoforms: their clinical implications, utilisation in diagnosis, prevention and new antiviral strategies","volume":"13","author":"Lazarevic","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/v18010023","article-title":"Key challenges in screening blood donors for hepatitis B virus","volume":"18","author":"Badawi","year":"2026","journal-title":"Viruses"},{"issue":"17","key":"10.1016\/j.jiph.2026.103312_bib52","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3390\/diagnostics15172261","article-title":"The \u201cGrey Zone\u201d in blood donor screening: a retrospective study and proposal for donor re-entry","volume":"15","author":"Tounsi","year":"2025","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib53","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12879-026-12699-8","article-title":"Implications of occult hepatitis B infection for blood donor management: a five-year evaluation from Western Saudi Arabia","volume":"26","author":"Tounsi","year":"2026","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2026.103312_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110184","article-title":"Exchanges in the 'a' determinant of the hepatitis B virus surface antigen revisited","volume":"599","author":"Pond\u00e9","year":"2024","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.jiph.2026.103312_bib55","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.23886","article-title":"Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection","volume":"52","author":"El Chaar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jiph.2026.103312_bib56","doi-asserted-by":"crossref","DOI":"10.2147\/IDR.S576715","article-title":"Hepatic viral reservoirs in concurrent HIV and HBV: from mechanistic insight to integrated cure strategies","volume":"19","author":"Bobadilla","year":"2026","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.jiph.2026.103312_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Lancet Gastroenterol & Hepatol"},{"issue":"5","key":"10.1016\/j.jiph.2026.103312_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101395","article-title":"The forgotten virus, hepatitis D: a review of epidemiology, diagnosis, and current treatment strategies","volume":"14","author":"Khattak","year":"2024","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.jiph.2026.103312_bib59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/v16030412","article-title":"Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg","volume":"16","author":"Meschi","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2026.103312_bib60","first-page":"2023","article-title":"High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable","volume":"13","author":"Wang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.jiph.2026.103312_bib61","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/v15051141","article-title":"The role of CTLA-4 in T cell exhaustion in chronic hepatitis B virus infection","volume":"15","author":"Apol","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.jiph.2026.103312_bib62","first-page":"703","article-title":"Human leukocyte antigen (HLA) class II association in chronic hepatitis B patients with hepatocellular carcinoma in a Malay population: A pilot study","volume":"36","author":"Krishnan","year":"2019","journal-title":"Trop Biomed"},{"issue":"1","key":"10.1016\/j.jiph.2026.103312_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40121-022-00725-6","article-title":"Metabolic syndrome, nonalcoholic fatty liver disease, and chronic hepatitis B: a narrative review","volume":"12","author":"Diao","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"2","key":"10.1016\/j.jiph.2026.103312_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11901-024-00662-7","article-title":"A review of hepatitis B reactivation risk on immunosuppressants with a focus on newer immunomodulators","volume":"23","author":"Dossaji","year":"2024","journal-title":"Curr Hepatol Rep"},{"issue":"10","key":"10.1016\/j.jiph.2026.103312_bib65","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jiad140","article-title":"Occult hepatitis B virus infection and liver fibrosis in Chinese patients","volume":"228","author":"Tang","year":"2023","journal-title":"J Infect Dis"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412600184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412600184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:46:46Z","timestamp":1787860006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187603412600184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S187603412600184X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103312","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult hepatitis B infection in Saudi Arabia: Molecular mechanisms, diagnostic challenges, and implications for HBV elimination","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103312"}}